Stanford stem cell scientist leads effort to prevent fraudulent treatment

Jul 01, 2010

Leading stem cell researchers from institutions around the world are issuing warnings about unproven stem cell therapies being marketed on the Internet and have launched a website to educate and protect patients seeking such treatments. Often conducted outside of the United States, most of these therapies have little or no benefit — and can be dangerous as well as costly.

"Many people are going into the hands of predators," said Irving Weissman, MD, director of the Stanford Institute for Stem Cell Biology and and immediate past president of the International Society for , or ISSCR. "They often mortgage their homes or borrow money to go abroad for these so-called treatments. They are away from their loved ones when they should have been together during the last months or years of their lives."

Weissman is the senior author of a report on this subject — "Patients Beware: Commercialized Stem Cell Treatments on the Web" — to be published in the July 2 issue of Cell Stem Cell. The report, which analyzes the potential risks to patients and outlines practices and guidelines to assess the validity of Internet claims, was produced by an ISSCR task force that he helped to establish.

Speaking at the ISSCR's annual meeting in June in San Francisco, Weissman, whose term as the group's president has just ended, told the audience of nearly 4,000 stem cell scientists, "If you Google 'stem cell therapies' you will find over 200 companies, some of which have your names as advisors, that claim they can grow , inject them back into the patient and cure almost any condition."

The use of quotes from well-regarded stem cell scientists and physicians is not uncommon on unscrupulous Internet websites, according to Weissman. Frequently these experts are unaware that their names are being used, and the quotes are fabricated or taken out-of-context from some other source.

As a result of the task force's efforts to publicize these and other abuses, the ISSCR recently launched a publicly available website (www.closerlookatstemcells.org) where patients can learn more about , learn what questions to ask of potential clinics and even submit a specific website for further investigation by the ISSCR.

When a company or clinic is submitted for investigation, the ISSCR will evaluate whether a medical ethics committee is involved to protect the rights of a patient and whether the proposed treatment will be supervised by an official regulatory body such as the European Medicines Agency or the U.S. Food and Drug Administration. It will provide the results of the inquiry on the patient website.

"If you think about this, it's an amazingly unusual thing for a body of scientists to do," said Weissman of the website. "Once you read those websites and see what they are doing to people, you begin to lose faith in human nature. They will take the last dollars and days of people's lives. But by asking a few simple questions, you'll learn whether they are trying to treat you — or your wallet."

Explore further: Parasitic worm genomes: largest-ever dataset released

add to favorites email to friend print save as pdf

Related Stories

Stem- cell research ethics revision urged

Sep 20, 2005

University of California-San Francisco scientists are urging a revision of stem-cell research ethics in advance of using the procedure to treat disease.

Calif. institute budgets stem cell funds

Oct 05, 2006

The California Institute for Regenerative Medicine has decided how to spend the $3 billion approved by the U.S. state's voters for stem cell research.

Stanford researchers find stem cells in colorectal tumors

Jun 04, 2007

Researchers at the Stanford University School of Medicine have identified the cancer stem cells that propagate tumors in colon and rectal cancer, a discovery that could lead to improved treatment of this deadly cancer.

House bill funds embryonic stem cell study

Jan 10, 2007

As the U.S. House seeks to expand embryonic stem cell research funding, the White House is promoting stem cell development methods that don't harm embryos.

Recommended for you

Parasitic worm genomes: largest-ever dataset released

2 hours ago

The largest collection of helminth genomic data ever assembled has been published in the new, open-access WormBase-ParaSite. Developed jointly by EMBL-EBI and the Wellcome Trust Sanger Institute, this new ...

Bitter food but good medicine from cucumber genetics

22 hours ago

High-tech genomics and traditional Chinese medicine come together as researchers identify the genes responsible for the intense bitter taste of wild cucumbers. Taming this bitterness made cucumber, pumpkin ...

New button mushroom varieties need better protection

Nov 27, 2014

A working group has recently been formed to work on a better protection of button mushroom varieties. It's activities are firstly directed to generate consensus among the spawn/breeding companies to consider ...

Cataloguing 10 million human gut microbial genes

Nov 25, 2014

Over the past several years, research on bacteria in the digestive tract (gut microbiome) has confirmed the major role they play in our health. An international consortium, in which INRA participates, has developed the most ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.